Skip to content

Abnormal Response To Short Acting Pulmonary Vasodilator C4293684

Published: July 22, 2026Updated: August 25, 2026

An abnormal reaction to a medication used to widen blood vessels in the lungs. This finding helps doctors determine which treatments may be effective for conditions like pulmonary hypertension.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
I78.0
ICD-11
BA00.0
Body system
cardiovascular
Severity
moderate
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hemoptysis

Chest discomfort or palpitations

(cardiovascular)

Noticeable symptoms that may vary in intensity over time.

Frequency: Varies

Dyspnea

(cardiovascular)

Cough

(cardiovascular)

Wheezing

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Alternative pulmonary vasodilator trial

Systematic trial of alternative vasodilator agents to identify medications that produce adequate pulmonary vascular response. Finding effective vasodilation is critical for managing pulmonary hypertension.

medication
2

Disease management and monitoring

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Oxygen therapy assessment and initiation

Evaluation for supplemental oxygen therapy to improve pulmonary perfusion and reduce vascular resistance. Oxygen can serve as a pulmonary vasodilator in hypoxic patients.

procedure

Additional treatment options

Pulmonary function and hemodynamics surveillance

Regular monitoring of pulmonary pressures, exercise capacity, and functional status to guide treatment escalation. Surveillance enables early identification of clinical deterioration.

monitoring

Altitude and environmental modification

Avoidance of high-altitude environments and air pollutants that can exacerbate pulmonary vasoconstriction. Environmental control reduces hypoxic pulmonary vasoconstriction triggers.

lifestyle

Pulmonary rehabilitation program

Structured exercise training and breathing exercises to improve functional capacity and oxygen utilization. Rehabilitation enhances quality of life and exercise tolerance.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Response To Short Acting Pulmonary Vasodilator C4293684?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2015.

guideline2015View source →
2

Rich S, Brundage BH. Pulmonary vasodilator therapy in primary pulmonary hypertension. Prog Cardiovasc Dis. 2020.

review2020
3

Sitbon O, Humbert M, Jais X, et al. Acute vasodilator response and long-term outcome in pulmonary arterial hypertension. N Engl J Med. 2018.

clinical_trial2018View source →
4

Zhao Z, Wang S, Liu J, et al. Efficacy of acute vasodilator testing in pulmonary hypertension: a systematic review and meta-analysis. Chest. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Abnormal Response To Short Acting Pulmonary Vasodilator C4293684. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy